The −56T HLA-G Promoter Polymorphism is Not Associated with Pre-eclampsia/Eclampsia in Australian and New Zealand Women

By Doherty Vicki   Rush Ashley   Brennecke Shaun   Moses Eric  

Hypertension in Pregnancy, Vol. 25, Iss. 2, 2006-07 ,pp. : 63-71

Informa Healthcare

Access to resources Recommend Favorite

HLA-G molecules in pregnancy and their possible role in assisted reproductive technology

By Rizzo Roberta  

Expert Review of Obstretrics and Gynecology, Vol. 4, Iss. 4, 2009-07 ,pp. : 455-470

Informa Healthcare

Access to resources Recommend Favorite

Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis

By Neale D.   Demasio K.   Illuzi J.   Chaiworapongsa T.   Romero R.   Mor G.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 13, Iss. 1, 2003-01 ,pp. : 39-44

Informa Healthcare

Access to resources Recommend Favorite

Pre-eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A>G melas mutation

By Moriarty K. T.   Mcfarland R.   Whittaker R.   Burch J.   Turnbull H. E.   Taylor R. W.   Turnbull D. M.  

Journal of Obstetrics & Gynaecology, Vol. 28, Iss. 3, 2008-04 ,pp. : 349-349

Informa Healthcare

Access to resources Recommend Favorite

Embryo selection criteria based on morphology VERSUS the expression of a biochemical marker (sHLA-G) and a graduated embryo score: prediction of pregnancy outcome

By Kotze Dirk   Hansen Polly   Keskintepe Levent   Snowden Ellen   Sher Geoffrey   Kruger Thinus  

Journal of Assisted Reproduction and Genetics, Vol. 27, Iss. 6, 2010-06 ,pp. : 309-316

Springer Publishing Company

Access to resources Recommend Favorite